Boosting the Anticancer Activity of Sunitinib Malate in Breast Cancer through Lipid Polymer Hybrid Nanoparticles Approach

被引:31
作者
Ahmed, Mohammed Muqtader [1 ]
Anwer, Md. Khalid [1 ]
Fatima, Farhat [1 ]
Aldawsari, Mohammed F. [1 ]
Alalaiwe, Ahmed [1 ]
Alali, Amer S. [1 ]
Alharthi, Abdulrahman I. [2 ]
Abul Kalam, Mohd [3 ,4 ]
机构
[1] Prince Sattam Bin Abdulaziz Univ, Dept Pharmaceut, Coll Pharm, POB 173, Al Kharj 11942, Saudi Arabia
[2] Prince Sattam Bin Abdulaziz Univ, Coll Sci & Humanities, Dept Chem, POB 83, Al Kharj 11942, Saudi Arabia
[3] King Saud Univ, Coll Pharm, Nanobiotechnol Res Unit, POB 2457, Riyadh 11451, Saudi Arabia
[4] King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh 11451, Saudi Arabia
关键词
sunitinib; lipoid; 90H; chitosan; nanoparticles; breast cancer; caspase; TYROSINE KINASE INHIBITOR; PLGA NANOPARTICLES; LOADED PLGA; FORMULATION; DELIVERY; CELLS; GENE;
D O I
10.3390/polym14122459
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
In the current study, lipid-polymer hybrid nanoparticles (LPHNPs) fabricated with lipoid-90H and chitosan, sunitinib malate (SM), an anticancer drug was loaded using lecithin as a stabilizer by employing emulsion solvent evaporation technique. Four formulations (SLPN1-SLPN4) were developed by varying the concentration of chitosan polymer. Based on particle characterization, SLPN4 was optimized with size (439 +/- 5.8 nm), PDI (0.269), ZP (+34 +/- 5.3 mV), and EE (83.03 +/- 4.9%). Further, the optimized formulation was characterized by FTIR, DSC, XRD, SEM, and in vitro release studies. In-vitro release of the drug from SPN4 was found to be 84.11 +/- 2.54% as compared with pure drug SM 24.13 +/- 2.67%; in 48 h, release kinetics followed the Korsmeyer-Peppas model with Fickian release mechanism. The SLPN4 exhibited a potent cytotoxicity against MCF-7 breast cancer, as evident by caspase 3, 9, and p53 activities. According to the findings, SM-loaded LPHNPs might be a promising therapy option for breast cancer.
引用
收藏
页数:15
相关论文
共 55 条
[1]   A Role for Notch Signalling in Breast Cancer and Endocrine Resistancesssss [J].
Acar, Ahmet ;
Simoes, Bruno M. ;
Clarke, Robert B. ;
Brennan, Keith .
STEM CELLS INTERNATIONAL, 2016, 2016
[2]   Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors [J].
Adams, Val R. ;
Leggas, Markos .
CLINICAL THERAPEUTICS, 2007, 29 (07) :1338-1353
[3]   RETRACTED: Optimized Icariin Phytosomes Exhibit Enhanced Cytotoxicity and Apoptosis-Inducing Activities in Ovarian Cancer Cells (Retracted Article) [J].
Alhakamy, Nabil A. ;
Fahmy, Usama A. ;
Badr-Eldin, Shaimaa M. ;
Ahmed, Osama A. A. ;
Asfour, Hani Z. ;
Aldawsari, Hibah M. ;
Algandaby, Mardi M. ;
Eid, Basma G. ;
Abdel-Naim, Ashraf B. ;
Awan, Zuhier A. ;
Alruwaili, Nabil K. ;
Mohamed, Amir I. .
PHARMACEUTICS, 2020, 12 (04)
[4]   Subtle variations in Pten dose determine cancer susceptibility [J].
Alimonti, Andrea ;
Carracedo, Arkaitz ;
Clohessy, John G. ;
Trotman, Lloyd C. ;
Nardella, Caterina ;
Egia, Ainara ;
Salmena, Leonardo ;
Sampieri, Katia ;
Haveman, William J. ;
Brogi, Edi ;
Richardson, Andrea L. ;
Zhang, Jiangwen ;
Pandolfi, Pier Paolo .
NATURE GENETICS, 2010, 42 (05) :454-U136
[5]   Tracking cells in epithelial acini by light sheet microscopy reveals proximity effects in breast cancer initiation [J].
Alladin, Ashna ;
Chaible, Lucas ;
del Valle, Lucia Garcia ;
Sabine, Reither ;
Loeschinger, Monika ;
Wachsmuth, Malte ;
Heriche, Jean-Karim ;
Tischer, Christian ;
Jechlinger, Martin .
ELIFE, 2020, 9 :1-20
[6]   Anticancer Efficacy of Self-Nanoemulsifying Drug Delivery System of Sunitinib Malate [J].
Alshahrani, Saad M. ;
Alshetaili, Abdullah S. ;
Alalaiwe, Ahmed ;
Alsulays, Bader B. ;
Anwer, Md Khalid ;
Al-Shdefat, Ramadan ;
Imam, Faisal ;
Shakeel, Faiyaz .
AAPS PHARMSCITECH, 2018, 19 (01) :123-133
[7]   Gefitinib loaded PLGA and chitosan coated PLGA nanoparticles with magnified cytotoxicity against A549 lung cancer cell lines [J].
Alshetaili, Abdullah S. .
SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2021, 28 (09) :5065-5073
[8]   Characteristics and anticancer properties of Sunitinib malate-loaded poly-lactic-co-glycolic acid nanoparticles against human colon cancer HT-29 cells lines [J].
Alshetaili, Abdullah S. ;
Anwer, Md Khalid ;
Alshahrani, Saad M. ;
Alalaiwe, Ahmed ;
Alsulays, Bader B. ;
Ansari, Mohammad Javed ;
Imam, Faisal ;
Alshehri, Sultan .
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2018, 17 (07) :1263-1269
[9]   Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats [J].
Anwer, Khalid ;
Mohammad, Muqtader ;
Ezzeldin, Essam ;
Fatima, Farhat ;
Alalaiwe, Ahmed ;
Iqbal, Muzaffar .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 14 :1587-1595
[10]   Preparation, Evaluation and Bioavailability Studies of Eudragit Coated PLGA Nanoparticles for Sustained Release of Eluxadoline for the Treatment of Irritable Bowel Syndrome [J].
Anwer, Md. K. ;
Al-Shdefat, Ramadan ;
Ezzeldin, Essam ;
Alshahrani, Saad M. ;
Alshetaili, Abdullah S. ;
Iqbal, Muzaffar .
FRONTIERS IN PHARMACOLOGY, 2017, 8